New Strategies in Gene and Cell Therapy for Neurological Disorders
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 794
Special Issue Editor
Special Issue Information
Dear Colleagues,
Neurological disorders encompass a diverse spectrum of conditions affecting the central and peripheral nervous systems, including neurodegenerative diseases, neurodevelopmental disorders, neuropsychiatric conditions, genetic and metabolic disorders, CNS tumors, and trauma-induced injuries. Gene and cell therapy holds immense promise for treating these disorders, offering potential solutions for previously intractable conditions. Recent advancements in gene editing technologies, vector systems, cell-based regenerative medicine, immunomodulatory therapies, and delivery strategies have opened up new avenues for therapeutic interventions.
This Special Issue aims to feature cutting-edge gene and cell therapy research across the broad landscape of neurological disorders. Special attention will be paid to emerging technologies, including, but not limited to, nanotechnology, novel vectors, innovative delivery strategies to overcome the blood–brain barrier, and immunomodulatory interventions. Furthermore, reports on clinical trials or regulatory aspects will also be paid similar attention. This Special Issue welcomes the submission of original research articles demonstrating novel approaches, comprehensive reviews synthesizing current knowledge, and perspective pieces discussing future directions.
By bringing together diverse expertise in gene and cell therapy, neuroscience, and clinical translation, this Special Issue aims to accelerate the development of more effective treatments for neurological disorders.
We are pleased to invite you to submit original research articles, reviews, and case studies that address the aforementioned topics. Submissions should provide new insights, present innovative methodologies, or offer comprehensive reviews of current knowledge.
This Special Issue aims to place a spotlight on both breakthrough advances and critical challenges in gene and cell therapy for neurological disorders, encompassing neurodevelopmental, neurodegenerative, and neuropsychiatric disorders, CNS tumors, CNS injury, and rare genetic neurological diseases. By bringing together cutting-edge research, we seek to provide a comprehensive overview of current trends, technological limitations, safety considerations, and promising solutions in therapeutic interventions. Special emphasis will be placed on identifying key bottlenecks and innovative approaches that could transform our understanding and implementation of these therapeutic strategies.
We look forward to receiving your contributions.
Dr. Jubayer Hossain
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene and cell therapy
- neurodegenerative diseases
- neurodevelopmental disorders
- neuropsychiatric conditions
- CNS tumors
- trauma and injury in the CNS
- blood–brain barrier
- neuroimmunology and immunomodulation
- peripheral nervous system disorders
- regenerative medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
